http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018033792-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6467c5ad483b83c3756a9662ddc46be
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-133
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
filingDate 2017-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2f19e651fd6b8f4452b20a8026171ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba7e1e9ade66ed2997252036bb1f2afc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d28d6b47bf3c67d9f38f46ab7105001a
publicationDate 2018-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2018033792-A3
titleOfInvention Ophthalmic pharmaceutical compositions and uses relating thereto
abstract The disclosure relates to ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt. Aspects of the disclosure further relate to uses and preparations of ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt, for correcting presbyopia and other ocular conditions in a subject.
priorityDate 2016-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015122853-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8524758-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016008278-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015174105-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5300114-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5972326-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8992952-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405615
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5910

Total number of triples: 37.